HK Stock Market Move | CMOC Group Limited (03993) shares rose by over 5% after the earnings report, with a 86.27% year-on-year increase in interim net profit attributable to the parent company. The company is further enhancing its gold business layout.
Luoyang Molybdenum Co., Ltd. (03993) rose over 5% after earnings; as of the time of writing, it was up 4.73%, trading at HKD 17.27, with a transaction volume of HKD 116 million.
CMOC Group Limited (03993) surged over 5% after earnings report, and as of the time of writing, it is up 4.73%, trading at HKD 17.27, with a transaction volume of HKD 116 million.
On August 19, CMOC Group Limited announced its interim results for 2026, reporting an operating income of approximately RMB 135.32 billion, a year-on-year increase of 42.78%; the net profit attributable to shareholders of the listed company was approximately RMB 16.152 billion, a year-on-year increase of 86.27%; basic earnings per share stood at RMB 0.76, with a cash dividend of RMB 0.95 per 10 shares (before tax). The debt-to-asset ratio was 52.16%, maintaining a reasonable level within the industry.
In terms of production operations, the company achieved a copper production volume of approximately 388,000 tons in the first half of the year, a year-on-year increase of 9.73%, continuing to rank among the top ten copper producers globally, with stable production operations across major mines and orderly progress towards annual operational goals. In addition, following the completion of the acquisition of the Odinson Gold Mine in Ecuador in 2025, this transaction further enhances the companys gold business layout, pushing the annual gold production capacity towards a target of over 20 tons, laying a foundation for creating a new profit growth pole.
Related Articles

HK Stock Market Move | SIMCERE PHARMA (02096) rose over 5% in early trading. Today, it will release its interim results, driven by significant growth in revenue from innovative drugs and business development.

HK Stock Market Move | ZHAOJIN MINING (01818) rose over 11%. The U.S. Treasury Department's expansion of long-term bond repurchases has boosted the precious metals market. The Federal Reserve's high interest rates are leading to a loosening of the cycle.

CMSC International: First Assigns JIANGXI BIO (06915) a Buy Rating with a Target Price of HK$23.6
HK Stock Market Move | SIMCERE PHARMA (02096) rose over 5% in early trading. Today, it will release its interim results, driven by significant growth in revenue from innovative drugs and business development.

HK Stock Market Move | ZHAOJIN MINING (01818) rose over 11%. The U.S. Treasury Department's expansion of long-term bond repurchases has boosted the precious metals market. The Federal Reserve's high interest rates are leading to a loosening of the cycle.

CMSC International: First Assigns JIANGXI BIO (06915) a Buy Rating with a Target Price of HK$23.6

RECOMMEND





